- Home
- TLPH vs AEI Comparison
TLPH vs AEI Comparison
Compare TLPH & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- AEI
- Stock Information
- Founded
- TLPH 2005
- AEI 2014
- Country
- TLPH United States
- AEI United States
- Employees
- TLPH N/A
- AEI N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- AEI Building operators
- Sector
- TLPH Health Care
- AEI Real Estate
- Exchange
- TLPH Nasdaq
- AEI Nasdaq
- Market Cap
- TLPH 10.6M
- AEI 10.9M
- IPO Year
- TLPH 2011
- AEI N/A
- Fundamental
- Price
- TLPH $0.52
- AEI $1.11
- Analyst Decision
- TLPH Strong Buy
- AEI
- Analyst Count
- TLPH 1
- AEI 0
- Target Price
- TLPH $6.00
- AEI N/A
- AVG Volume (30 Days)
- TLPH 50.8K
- AEI 120.5K
- Earning Date
- TLPH 08-13-2025
- AEI 08-12-2025
- Dividend Yield
- TLPH N/A
- AEI N/A
- EPS Growth
- TLPH N/A
- AEI N/A
- EPS
- TLPH N/A
- AEI N/A
- Revenue
- TLPH $27,000.00
- AEI $16,097,995.00
- Revenue This Year
- TLPH N/A
- AEI N/A
- Revenue Next Year
- TLPH $14,533.26
- AEI N/A
- P/E Ratio
- TLPH N/A
- AEI N/A
- Revenue Growth
- TLPH N/A
- AEI N/A
- 52 Week Low
- TLPH $0.43
- AEI $0.70
- 52 Week High
- TLPH $1.19
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- TLPH 61.24
- AEI 58.89
- Support Level
- TLPH $0.44
- AEI $0.98
- Resistance Level
- TLPH $0.52
- AEI $1.15
- Average True Range (ATR)
- TLPH 0.03
- AEI 0.11
- MACD
- TLPH 0.01
- AEI 0.01
- Stochastic Oscillator
- TLPH 93.89
- AEI 54.76
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.